Weed (BUDZ) Cash from Investing Activities (2010 - 2023)
Weed's (BUDZ) quarterly Cash from Investing Activities came in at $1.6 million in Q3 2023, up 16510.73% quarter-over-quarter from -$10000.0 in Q1 2023.
Weed (BUDZ) Cash from Investing Activities (2010 - 2023) Analysis & Trends
Weed's Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $1.6 million for Q3 2023.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to $1.6 million in Q3 2023; TTM through Jun 2024 was $1.6 million, a 16510.73% increase from a year earlier, with the FY2023 full-year figure at $1.6 million, up 29.76% from the prior year.
- Cash from Investing Activities rose to $1.6 million in Q3 2023 per BUDZ's latest filing, from -$10000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $1.6 million in Q3 2023 and bottomed at -$267499.0 in Q4 2021.
- The 4-year median for Cash from Investing Activities is -$3356.5 (2019), against an average of $253408.5.
- Biggest YoY gain for Cash from Investing Activities was 99.13% in 2019; the steepest drop was 99.13% in 2019.
- Year by year, Cash from Investing Activities stood at -$2979.0 in 2019, then soared by 5591.44% to $163590.0 in 2020, then tumbled by 263.52% to -$267499.0 in 2021, then jumped by 713.49% to $1.6 million in 2023.
- Per Business Quant, the three latest BUDZ Cash from Investing Activities figures stand at $1.6 million (Q3 2023), -$10000.0 (Q1 2023), and -$267499.0 (Q4 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Weed | 3.10 Mn | 3.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | -10,000.00 |
| Mar 31, 2023 | -10,000.00 |
| Dec 31, 2021 | -267,499.00 |
| Dec 31, 2021 | -267,499.00 |
| Mar 31, 2021 | -3,734.00 |
| Mar 31, 2021 | -3,734.00 |
| Sep 30, 2020 | 163,590.00 |
| Sep 30, 2020 | 163,590.00 |
| Mar 31, 2019 | -2,979.00 |
| Mar 31, 2019 | -2,979.00 |
| Sep 30, 2018 | -485,761.00 |
| Sep 30, 2018 | -485,761.00 |
| Jun 30, 2018 | -50,067.00 |
| Jun 30, 2018 | -50,067.00 |
| Mar 31, 2018 | -340,653.00 |
| Mar 31, 2018 | -340,653.00 |
| Dec 31, 2017 | -24,755.00 |
| Dec 31, 2017 | -24,755.00 |